{
  "main_header": {
    "sid": 1207271,
    "name": "Ionis Pharmaceuticals, Inc.",
    "stock_name": "Ionis Pharmaceuticals, Inc.",
    "full_name": "Ionis Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/ionis-pharmaceuticals-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "81.81",
    "chg": 0.5,
    "chgp": "0.61%",
    "dir": 1,
    "prev_price": "81.31",
    "mcapval": "9,722.87",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US4622221004",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.48 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ionis-pharmaceuticals-inc-1207271-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Ionis Pharmaceuticals Hits New 52-Week High of $74.68",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ionis-pharmaceuticals-hits-new-52-week-high-of-7468-3661886",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/IonisPharmaceut_priceRelatedfactors_3661886.png",
        "date": "2025-10-31 16:02:03",
        "description": "Ionis Pharmaceuticals, Inc. achieved a new 52-week high of USD 74.68 on October 30, 2025, reflecting strong performance in the pharmaceuticals sector. The company reported a significant 86.4% increase in stock value over the past year and a 243.47% growth in net sales, reaching USD 452.05 million."
      },
      {
        "title": "Ionis Pharmaceuticals Hits New 52-Week High of $73.92",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ionis-pharmaceuticals-hits-new-52-week-high-of-7392-3626577",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/IonisPharmaceut_priceRelatedfactors_3626577.png",
        "date": "2025-10-16 18:09:46",
        "description": "Ionis Pharmaceuticals, Inc. achieved a new 52-week high, reflecting its strong performance in the pharmaceuticals sector. The company reported significant growth in net sales and stock value over the past year, supported by high institutional holdings and improved operational efficiency amid declining raw material costs."
      },
      {
        "title": "Ionis Pharmaceuticals Hits New 52-Week High of $72.15",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ionis-pharmaceuticals-hits-new-52-week-high-of-7215-3622744",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/IonisPharmaceut_priceRelatedfactors_3622744.png",
        "date": "2025-10-15 16:46:42",
        "description": "Ionis Pharmaceuticals, Inc. achieved a new 52-week high of USD 72.15 on October 14, 2025, reflecting strong performance in the pharmaceuticals sector. The company reported a 243.47% increase in net sales, reaching USD 452.05 million, and has demonstrated significant stock growth over the past year."
      },
      {
        "title": "Ionis Pharmaceuticals Hits New 52-Week High of $71.87",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ionis-pharmaceuticals-hits-new-52-week-high-of-7187-3607965",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/IonisPharmaceut_priceRelatedfactors_3607965.png",
        "date": "2025-10-09 20:00:44",
        "description": "Ionis Pharmaceuticals, Inc. achieved a new 52-week high of USD 71.87 on October 8, 2025, reflecting strong performance in the pharmaceuticals sector. The company reported a 243.47% increase in net sales, reaching USD 452.05 million, despite facing challenges such as negative return on equity and high institutional ownership."
      },
      {
        "title": "Ionis Pharmaceuticals Hits New 52-Week High of $70.14",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ionis-pharmaceuticals-hits-new-52-week-high-of-7014-3601547",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/IonisPharmaceut_priceRelatedfactors_3601547.png",
        "date": "2025-10-07 21:38:14",
        "description": "Ionis Pharmaceuticals, Inc. achieved a new 52-week high, reflecting its strong performance in the pharmaceuticals sector. The company reported a substantial increase in net sales and recorded its highest operating cash flow. With impressive stock performance and high institutional holdings, Ionis is well-positioned in its industry."
      },
      {
        "title": "Ionis Pharmaceuticals Hits New 52-Week High of $69.25",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ionis-pharmaceuticals-hits-new-52-week-high-of-6925-3595562",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/IonisPharmaceut_priceRelatedfactors_3595562.png",
        "date": "2025-10-06 17:24:00",
        "description": "Ionis Pharmaceuticals has achieved a new 52-week high, reflecting its strong performance in the biotechnology sector. The company reported a substantial increase in net sales and a decrease in raw material costs, while maintaining full institutional ownership, indicating confidence in its strategic direction despite ongoing losses."
      },
      {
        "title": "Ionis Pharmaceuticals Hits New 52-Week High of $66.23",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ionis-pharmaceuticals-hits-new-52-week-high-of-6623-3588314",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/IonisPharmaceut_priceRelatedfactors_3588314.png",
        "date": "2025-10-02 22:27:29",
        "description": "Ionis Pharmaceuticals, Inc. achieved a new 52-week high of USD 66.23 on October 1, 2025, reflecting strong performance in the pharmaceuticals sector. The company reported a 65.37% increase in stock performance over the past year and a significant 243.47% growth in net sales, reaching USD 452.05 million."
      },
      {
        "title": "Ionis Pharmaceuticals Hits New 52-Week High of $65.55",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ionis-pharmaceuticals-hits-new-52-week-high-of-6555-3585994",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/IonisPharmaceut_priceRelatedfactors_3585994.png",
        "date": "2025-10-01 16:31:56",
        "description": "Ionis Pharmaceuticals, Inc. achieved a new 52-week high, reflecting its strong performance in the pharmaceuticals and biotechnology sector. The company reported significant growth in net sales and stock value over the past year, alongside high institutional holdings, indicating investor confidence despite ongoing losses."
      },
      {
        "title": "Is Ionis Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-ionis-pharmaceuticals-inc-technically-bullish-or-bearish-3545457",
        "imagepath": "",
        "date": "2025-09-20 19:12:09",
        "description": "As of 7 July 2025, the technical trend for Ionis Pharmaceuticals, Inc. has changed from mildly bearish to bullish. The weekly and monthly MACD indicators are both bullish, supporting the positive trend. However, the RSI readings are bearish on both weekly and monthly time frames, indicating potential overbought conditions. The Bollinger Bands suggest a mildly bullish stance on the weekly and bullish on the monthly. Daily moving averages are bullish, while the KST is bullish weekly and mildly bullish monthly. Dow Theory shows no trend weekly but is mildly bullish monthly, and the OBV is bullish monthly.\n\nIn terms of performance, Ionis Pharmaceuticals has significantly outperformed the S&P 500 over the past month (42.16% vs. 2.33%) and year-to-date (76.60% vs. 12.22%), but it has lagged behind the benchmark over the longer three, five, and ten-year periods. Overall, the current technical stance is bullish, bu..."
      }
    ],
    "total": 15,
    "sid": "1207271",
    "stock_news_url": "https://www.marketsmojo.com/news/ionis-pharmaceuticals-inc-1207271"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Ionis Pharmaceuticals Hits New 52-Week High of $74.68

2025-10-31 16:02:03

Ionis Pharmaceuticals, Inc. achieved a new 52-week high of USD 74.68 on October 30, 2025, reflecting strong performance in the pharmaceuticals sector. The company reported a significant 86.4% increase in stock value over the past year and a 243.47% growth in net sales, reaching USD 452.05 million.

Read More

Ionis Pharmaceuticals Hits New 52-Week High of $73.92

2025-10-16 18:09:46

Ionis Pharmaceuticals, Inc. achieved a new 52-week high, reflecting its strong performance in the pharmaceuticals sector. The company reported significant growth in net sales and stock value over the past year, supported by high institutional holdings and improved operational efficiency amid declining raw material costs.

Read More

Ionis Pharmaceuticals Hits New 52-Week High of $72.15

2025-10-15 16:46:42

Ionis Pharmaceuticals, Inc. achieved a new 52-week high of USD 72.15 on October 14, 2025, reflecting strong performance in the pharmaceuticals sector. The company reported a 243.47% increase in net sales, reaching USD 452.05 million, and has demonstrated significant stock growth over the past year.

Read More

Ionis Pharmaceuticals Hits New 52-Week High of $71.87

2025-10-09 20:00:44

Ionis Pharmaceuticals, Inc. achieved a new 52-week high of USD 71.87 on October 8, 2025, reflecting strong performance in the pharmaceuticals sector. The company reported a 243.47% increase in net sales, reaching USD 452.05 million, despite facing challenges such as negative return on equity and high institutional ownership.

Read More

Ionis Pharmaceuticals Hits New 52-Week High of $70.14

2025-10-07 21:38:14

Ionis Pharmaceuticals, Inc. achieved a new 52-week high, reflecting its strong performance in the pharmaceuticals sector. The company reported a substantial increase in net sales and recorded its highest operating cash flow. With impressive stock performance and high institutional holdings, Ionis is well-positioned in its industry.

Read More

Ionis Pharmaceuticals Hits New 52-Week High of $69.25

2025-10-06 17:24:00

Ionis Pharmaceuticals has achieved a new 52-week high, reflecting its strong performance in the biotechnology sector. The company reported a substantial increase in net sales and a decrease in raw material costs, while maintaining full institutional ownership, indicating confidence in its strategic direction despite ongoing losses.

Read More

Ionis Pharmaceuticals Hits New 52-Week High of $66.23

2025-10-02 22:27:29

Ionis Pharmaceuticals, Inc. achieved a new 52-week high of USD 66.23 on October 1, 2025, reflecting strong performance in the pharmaceuticals sector. The company reported a 65.37% increase in stock performance over the past year and a significant 243.47% growth in net sales, reaching USD 452.05 million.

Read More

Ionis Pharmaceuticals Hits New 52-Week High of $65.55

2025-10-01 16:31:56

Ionis Pharmaceuticals, Inc. achieved a new 52-week high, reflecting its strong performance in the pharmaceuticals and biotechnology sector. The company reported significant growth in net sales and stock value over the past year, alongside high institutional holdings, indicating investor confidence despite ongoing losses.

Read More

Is Ionis Pharmaceuticals, Inc. technically bullish or bearish?

2025-09-20 19:12:09

As of 7 July 2025, the technical trend for Ionis Pharmaceuticals, Inc. has changed from mildly bearish to bullish. The weekly and monthly MACD indicators are both bullish, supporting the positive trend. However, the RSI readings are bearish on both weekly and monthly time frames, indicating potential overbought conditions. The Bollinger Bands suggest a mildly bullish stance on the weekly and bullish on the monthly. Daily moving averages are bullish, while the KST is bullish weekly and mildly bullish monthly. Dow Theory shows no trend weekly but is mildly bullish monthly, and the OBV is bullish monthly. In terms of performance, Ionis Pharmaceuticals has significantly outperformed the S&P 500 over the past month (42.16% vs. 2.33%) and year-to-date (76.60% vs. 12.22%), but it has lagged behind the benchmark over the longer three, five, and ten-year periods. Overall, the current technical stance is bullish, bu...

Read More

View All News